S. Timko - May 17, 2024 Form 4 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Role
EVP, CFO
Signature
Elizabeth C. Radigan, Attorney-in-Fact for Thomas Timko
Stock symbol
DBD
Transactions as of
May 17, 2024
Transactions value $
$0
Form type
4
Date filed
5/21/2024, 04:33 PM
Previous filing
Mar 5, 2024
Next filing
Aug 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DBD Common Stock Award $0 +28K $0.00 28K May 17, 2024 Direct F1, F2
transaction DBD Common Stock Award $0 +18.8K +67% $0.00 46.8K May 17, 2024 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DBD Employee Stock Option (right to buy) Award $0 +93.9K $0.00 93.9K May 17, 2024 Common Stock 93.9K $44.54 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of Restricted Stock Units granted under the Diebold Nixdorf, Incorporated 2023 Equity and Incentive Plan, as amended, and vesting in annual increments of 1/3, 1/3, 1/3 beginning March 1, 2025; each Restricted Stock Unit represents a contingent right to receive one share of Diebold Nixdorf, Incorporated common stock.
F2 Number includes Restricted Stock Units.
F3 Award of Restricted Stock Units granted under the Diebold Nixdorf, Incorporated 2023 Equity and Incentive Plan, as amended, and vesting in annual increments of 1/4, 1/4, 1/4, 1/4 beginning on January 19, 2025; each Restricted Stock Unit represents a contingent right to receive one share of Diebold Nixdorf, Incorporated common stock.
F4 Granted under the Diebold Nixdorf, Incorporated 2023 Equity and Incentive Plan, as amended; option generally vests on the fourth anniversary of January 19, 2024, and is generally exercisable in 40%, 30%, and 30% tranches upon the Issuer's common stock, par value $0.01 per share, achieving 20-day trading average price hurdles of $65.00, $85.00, and $95.00, respectively, by January 19, 2028.